Acadia Pharmaceuticals Inc. (ACAD)
NASDAQ · Healthcare
Acadia Pharmaceuticals Inc. Revenue 2009–2025
Acadia Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Acadia Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 268.1 M, a 9.72% increase year-over-year.
- Acadia Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 1.1 B, a 16.01% increase year-over-year.
- Acadia Pharmaceuticals Inc. annual revenue for 2025 was 1.1 B, a 11.87% increase from 2024.
- Acadia Pharmaceuticals Inc. annual revenue for 2024 was 957.8 M, a 31.85% increase from 2023.
- Acadia Pharmaceuticals Inc. annual revenue for 2023 was 726.4 M, a 40.45% increase from 2022.
- Acadia Pharmaceuticals Inc. annual revenue for 2022 was 517.2 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Acadia Pharmaceuticals Inc. Earnings — FAQ
Acadia Pharmaceuticals Inc. (ACAD) earnings over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ACAD's earnings history?
The chart and table above show Acadia Pharmaceuticals Inc.'s earnings by year and by quarter, including the growth rate.